Journal of Clinical Endocrinology & Metabolism, Vol 65, 1164-1167, Copyright © 1987 by Endocrine Society

ARTICLES

Changing pituitary reactivity to follicle-stimulating hormone and luteinizing hormone-releasing hormone after induced ovulatory cycles and after anovulation in patients with polycystic ovarian disease

J Blankstein, J Rabinovici, M Goldenberg, J Shaley, A Mehta, DM Serr and S Mashiach
Department of Obstetrics and Gynecology, Sheba Medical Center, Tel- Hashomer, Israel.

Pituitary reactivity to GnRH, characteristic of polycystic ovarian disease (PCOD), has been attributed both to a primary ovarian cause and to hypothalamic-pituitary dysfunction. If the heightened pituitary reactivity characteristic of PCOD patients is secondary to chronic anovulation, ovulatory cycles should produce changes in the LH to FSH ratio and reduce the augmented response to GnRH. In a randomized cross- over study of 10 women with PCOD, GnRH (100 micrograms) was injected iv on the fifth day of 2 consecutive cycles, 1 of them following anovulation and progesterone withdrawal bleeding and the other following an induced ovulatory cycle. Mean basal plasma 17 beta- estradiol, progesterone, and FSH levels were similar after ovulatory and anovulatory cycles. However, mean basal serum testosterone (P less than 0.05) and LH (P less than 0.01) levels were significantly lower, as were LH levels 30, 60, and 90 min (P less than 0.01) and FSH levels 60 and 90 min (P less than 0.05) after GnRH injection, after an ovulatory cycle than after an anovulatory cycle. The pituitary response to GnRH in those PCOD patients, therefore, was more normal after an ovulatory cycle than after an anovulatory cycle. We conclude that the heightened pituitary reactivity characteristic of PCOD patients is associated with chronic anovulation.

This article has been cited by other articles:

				P. J. Marsden, A. P. Murdoch, and R. Taylor Adipocyte insulin action in hypogonadotrophic hypogonadism Hum. Reprod., August 1, 2000; 15(8): 1672 - 1678. [Abstract] [Full Text] [PDF]

				P. J.Marsden, A. P. Murdoch, and R. Taylor Adipocyte insulin action following ovulation in polycystic ovarian syndrome Hum. Reprod., September 1, 1999; 14(9): 2216 - 2222. [Abstract] [Full Text] [PDF]

				M.H.A. van Hooff, M. van der Meer, C.B. Lambalk, and J. Schoemaker Variation of luteinizing hormone and androgens in oligomenorrhoea and its implications for the study of polycystic ovary syndrome Hum. Reprod., July 1, 1999; 14(7): 1684 - 1689. [Abstract] [Full Text] [PDF]

				A. E. Taylor, B. McCourt, K. A. Martin, E. J. Anderson, J. M. Adams, D. Schoenfeld, and J. E. Hall Determinants of Abnormal Gonadotropin Secretion in Clinically Defined Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2248 - 2256. [Abstract] [Full Text] [PDF]

				J. E. Nestler and D. J. Jakubowicz Decreases in Ovarian Cytochrome P450c17{alpha} Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary Syndrome N. Engl. J. Med., August 29, 1996; 335(9): 617 - 623. [Abstract] [Full Text] [PDF]